This webinar will provide an in-depth review of cerebral amyloid angiopathy and vascular dementia, including their epidemiology, pathology, diagnosis, and management. It will also explore the vascular risks and complications associated with emerging Alzheimer’s monoclonal antibody therapies—aducanumab, lecanemab, and donanemab with a focus on amyloid-related imaging abnormalities (ARIA) and their implications for clinical practice.

Target Audience

Physicians
Physicians Assistants
Advanced Practice Nurses
Registered Nurses
Licensed Practical Nurses

Learning Objectives

Learners will be able to:

Identify different types and clinical differences between these types of dementias
Describe pathophysiology and clinical manifestations of CAA
Identify the most updated diagnostic criteria for CAA, including but not limited to clinical, radiographic, and autopsy findings
Discuss the risks, benefits, and alternative options to antithrombotic therapy in patient with CAA
Discuss clinical presentation and management of vascular dementia

Course summary

Available credit:

1.00 AMA PRA Category 1 Credit™
TeleSpecialists is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

TeleSpecialists designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course opens:

05/13/2025

Course expires:

09/25/2025

Event starts:

06/24/2025 - 12:00pm EDT

Event ends:

06/24/2025 - 1:00pm EDT

Add to calendar:

Rating:

Speaker(s)